VanEck Pharmaceutical (Global) (PPH) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 03 November 2025 | Trade in progress | 9.94% | |
| 02 January 2024 | 02 December 2024 | 10.14% | 11.1% |
| 03 January 2023 | 01 November 2023 | -3.62% | -4.36% |
| 01 February 2022 | 01 September 2022 | -7.17% | -12.03% |
| 03 May 2021 | 01 December 2021 | 2.16% | 3.76% |
| Total Return | 11.44% | ||
The monthly data for VanEck Pharmaceutical (Global) (exchange: XNAS symbol: PPH) was last updated 27 Dec 2025 05:15. Data for this ETF is available from 04 Jan 2021 - 26 Dec 2025.
